Vicebio: Funding, Investors & Team (Oct 2026)
Vicebio is dedicated to using Molecular Clamp Technology to develop vaccines for upcoming respiratory viruses. The company specializes in producing new vaccines to protect against dangerous respiratory viral infections.
Vicebio has raised $100M across 1 funding round on record, the most recent a Series B of $100M announced in Sep 2024.
That round is above the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Vicebio Company Profile and Key Stats
Latest funding round on record: Sep 2024.
Vicebio Funding Rounds
Vicebio Founders and Leadership Team
No contact details are on record for this team yet.
Vicebio Funding Compared to Other Biotechnology Startups
Vicebio's latest round of $100M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Vicebio in Biotechnology and London
Companies Similar to Vicebio
Microbiotica develops treatments involving live bacteria found in the human microbiome, aiming to identify…
OMass Technologies is a drug discovery company exploiting novel mass spectrometry platforms to develop…
HydRegen, based in Oxford, UK, is a biotech firm that offers eco-friendly alternatives for the production of…
R1 Therapeutics is a clinical‑stage biopharmaceutical company focused on discovering and developing new drug…
The perfect package for any general surgical trainee or resident. Progress from beginner to advanced surgical…
Argonaute RNA company research projects build on existing intellectual property.
An innovative C elegans company that serves the biotech, nutrition, and other industries and fields of study…
ViaNautis, previously known as SomaServe, was established in 2018 as a separate entity from UCL under the…
Alchemab is harnessing the naturally protective power of patient antibodies to keep people free of…
Biodexa Pharmaceuticals is an international specialty pharmaceutical company focused on oncology and other…
Concert Bio helps businesses create optimal microbial communities.
RQ Bio is a biotechnology company that develops long-acting monoclonal antibodies against seasonal influenza…
Vicebio Funding FAQs
What does Vicebio do?
Vicebio is dedicated to using Molecular Clamp Technology to develop vaccines for upcoming respiratory viruses. The company specializes in producing new vaccines to protect against dangerous respiratory viral infections.
How much funding has Vicebio raised?
Vicebio has raised $100M across 1 round on record. The most recent is a Series B of $100M announced in Sep 2024.
When did Vicebio last raise funding?
Vicebio's most recent funding round on record is a Series B of $100M, announced in Sep 2024.
Who founded Vicebio?
FundedIQ lists Emmanuel Hanon (Founder) at Vicebio.
Where is Vicebio headquartered?
Vicebio is based in London, England, United Kingdom.
How many employees does Vicebio have?
Vicebio is in the 1-10 employee band.
How does Vicebio's funding compare to other Biotechnology startups?
Vicebio's latest round of $100M is above the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Vicebio Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Vicebio is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.